Vitamin E Alpha-Tocopherols to Prevent Recurrent Stroke in Patients with a Minor Neurovascular Event
Date of Award
4-1-2021
Document Type
Open Access Thesis
Degree Name
Master of Medical Science (MMSc)
First Advisor
Charles Wira, MD
Abstract
Minor ischemic strokes and transient ischemic attacks involve impaired perfusion to corresponding brain regions leading to neurological deficits that may or may not resolve after the event. Adults suffering one of these minor neurovascular events have high odds of a recurrent stroke within the first 90 days, mitigated but not prevented by standard treatment of clopidogrel and aspirin. Vitamin E alpha-tocopherols have been shown to reduce platelet aggregation, potentiate aspirin, and reduce ischemic damage. This study will assess the efficacy of vitamin E alpha-tocopherol, in addition to the standard treatment, on stroke recurrence in adults with a minor neurovascular event compared to the standard treatment alone. In this randomized, double-blinded, placebo-controlled trial, participants will receive the standard treatment of clopidogrel and aspirin with either vitamin E alpha-tocopherol or placebo supplements. This study may help decrease the proportion of stroke recurrence and may ultimately reduce morbidity and mortality.
Recommended Citation
Guirguis, Veronica, "Vitamin E Alpha-Tocopherols to Prevent Recurrent Stroke in Patients with a Minor Neurovascular Event" (2021). Yale School of Medicine Physician Associate Program Theses. 113.
https://elischolar.library.yale.edu/ysmpa_theses/113
